Alpha 2.0
Login Register
» Authors » Lucio Loreggian

Lucio Loreggian

Explore the profile of Lucio Loreggian including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 174
Followers 0
Related Specialties
Oncology
General Surgery
Otorhinolaryngology
Top 10 Co-Authors
Federico Rea
Giuseppe Marulli
Adolfo Favaretto
Gino Marioni
Giulia Pasello
Cristiano Breda
Guido Sotti
Alberto Staffieri
Stella Blandamura
Luciano Giacomelli
Published In
Lung Cancer
Anticancer Res
Eur Arch Otorhinolaryngol
Cancer
Lasers Surg Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM)
Fasanaro E, Del Bianco P, Groff E, Riva A, Petrangolini G, Busato F, et al.
Cancers (Basel) . 2022 Dec; 14(24). PMID: 36551677
Background: In patients affected by head and neck squamous cell carcinoma, the onset of severe oral mucositis is a decisive factor in completing concurrent chemo-radiotherapy, and few interventions have demonstrated...
2.
Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC
Ardizzoni A, Tiseo M, Boni L, Di Maio M, Buffoni L, Belvedere O, et al.
Lung Cancer . 2016 Sep; 100:30-37. PMID: 27597278
Background: Chemo-radiotherapy is standard of care in the treatment of unresectable stage III NSCLC. We aimed at assessing whether the addition of concurrent taxane-chemotherapy to thoracic irradiation following chemotherapy was...
3.
Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment
Bonanno L, Zago G, Marulli G, Del Bianco P, Schiavon M, Pasello G, et al.
Onco Targets Ther . 2016 Jul; 9:3671-81. PMID: 27382305
Objectives: If concurrent chemoradiotherapy cannot be performed, induction chemotherapy followed by radical-intent surgical treatment is an acceptable option for non primarily resectable non-small-cell lung cancers (NSCLCs). No markers are available...
4.
Results of surgical resection after induction chemoradiation for Pancoast tumours †
Marulli G, Battistella L, Perissinotto E, Breda C, Favaretto A, Pasello G, et al.
Interact Cardiovasc Thorac Surg . 2015 Mar; 20(6):805-11. PMID: 25757477
Objectives: Pancoast tumour is a rare neoplasia in which the optimal therapeutic management is still controversial. The traditional treatment of Pancoast tumour (surgery, radiotherapy or a combination of both) have...
5.
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): a prospective longitudinal study
Busetto M, Fusco V, Corbella F, Bolzan M, Pavanato G, Bonetti B, et al.
Radiother Oncol . 2013 Aug; 109(2):303-10. PMID: 23932151
Background And Purpose: Oropharyngeal mycosis (OPM) is a complication of radiotherapy (RT) treatments for head and neck (H&N) cancer, worsening mucositis and dysphagia, causing treatment interruptions and increasing overall treatment...
6.
Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM)
Pasello G, Marulli G, Polo V, Breda C, Bonanno L, Loreggian L, et al.
Anticancer Res . 2012 Dec; 32(12):5393-9. PMID: 23225442
Aim: The objective of this study was the retrospective evaluation of tolerability and activity of pemetrexed with carboplatin (AC) or cisplatin (AP) as neoadjuvant chemotherapy in a consecutive series of...
7.
A prognostic role for Nm23-H1 in laryngeal carcinoma treated with postoperative radiotherapy: an introductory investigation
Lionello M, Blandamura S, Agostini M, Staffieri C, Lovato A, Tealdo G, et al.
Eur Arch Otorhinolaryngol . 2012 Sep; 270(1):197-203. PMID: 23010793
Postoperative RT is generally recommended for laryngeal carcinomas (LSCCs) at high risk of recurrence after surgery. There are currently no clinicopathological parameters available to predict response to such adjuvant RT...
8.
High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study
Lionello M, Blandamura S, Loreggian L, Ottaviano G, Giacomelli L, Marchese-Ragona R, et al.
J Oral Pathol Med . 2011 Sep; 41(2):136-40. PMID: 21943204
Background: There are currently no clinical or pathological parameters able to predict response to adjuvant radiotherapy (RT) in laryngeal squamous cell carcinoma (LSCC). Few studies have investigated the molecular pathways...
9.
Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression
Marioni G, Blandamura S, Loreggian L, Koussis H, Lionello M, Giacomelli L, et al.
Eur Arch Otorhinolaryngol . 2011 Aug; 268(12):1779-87. PMID: 21842202
Patients with head and neck squamous cell carcinoma (SCC) respond very differently to radiotherapy (RT). Since clinical factors cannot accurately predict its effects, biological parameters have been investigated, including tumor...
10.
Preoperative concomitant chemo-radiotherapy in superior sulcus tumour: A mono-institutional experience
Favaretto A, Pasello G, Loreggian L, Breda C, Braccioni F, Marulli G, et al.
Lung Cancer . 2009 Jul; 68(2):228-33. PMID: 19632000
Unlabelled: Superior sulcus tumour (SST) is an uncommon neoplasia whose optimal treatment remains controversial. Usually resected after induction RT or treated with definitive chemo-radiotherapy, it has recently aroused more interest...